Quick Answer: Headache is a common side effect of tirzepatide, affecting 1 in 10 to 1 in 100 people, typically mild and manageable with hydration, blood glucose monitoring, and simple analgesia
Safety has improved since the FDA got oversight over bulk compounders
However, it is important to clarify that GLP-1 medications do not produce the same addictive effects as some substances that can lead to dependency
What is the recommended frequency for vitamin B12 injections in a patient with a vitamin B12 deficiency?
Comparing semaglutide and tirzepatide side effects reveals that both medications share this fatigue profile, though individual responses vary
Choose subcutaneous tissue (areas with more fat), like the stomach or outer thigh, to minimize discomfort and avoid areas with muscle or scars